EE9400257A - Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks - Google Patents

Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks

Info

Publication number
EE9400257A
EE9400257A EE9400257A EE9400257A EE9400257A EE 9400257 A EE9400257 A EE 9400257A EE 9400257 A EE9400257 A EE 9400257A EE 9400257 A EE9400257 A EE 9400257A EE 9400257 A EE9400257 A EE 9400257A
Authority
EE
Estonia
Prior art keywords
quinoline
preparation
pharmaceutical composition
carboxamide compound
carboxamide
Prior art date
Application number
EE9400257A
Other languages
English (en)
Inventor
Abramsky Oded
Karussis Dimitrios
Lehamann Dan
Slavin Shimon
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of EE9400257A publication Critical patent/EE9400257A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EE9400257A 1991-10-09 1994-11-17 Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks EE9400257A (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9102909A SE469368B (sv) 1991-10-09 1991-10-09 Ny anvaendning av linomide foer tillverkning av laekemedel foer behandling av multiple sclerosis (ms)

Publications (1)

Publication Number Publication Date
EE9400257A true EE9400257A (et) 1996-02-15

Family

ID=20383935

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400257A EE9400257A (et) 1991-10-09 1994-11-17 Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks

Country Status (11)

Country Link
US (1) US5580882A (et)
EP (1) EP0607282A1 (et)
JP (1) JPH06511488A (et)
KR (1) KR940702726A (et)
AU (1) AU653647B2 (et)
CA (1) CA2120712A1 (et)
EE (1) EE9400257A (et)
NO (1) NO941273L (et)
PT (1) PT100937A (et)
SE (1) SE469368B (et)
WO (1) WO1993006829A1 (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302490D0 (sv) * 1993-07-26 1993-07-26 Kabi Pharmacia Ab New use of old drugs
SE9400809D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of quinoline-3-carboxamide compounds
SE9400810D0 (sv) * 1994-03-10 1994-03-10 Pharmacia Ab New use of Quinoline-3-carboxamide compounds
EP0685466A1 (de) * 1994-06-02 1995-12-06 Ciba-Geigy Ag 3-Heteroaliphatyl- und 3-Hetero-(aryl)aliphatyl-2(1H)-chinolonderivate
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
JP2001503411A (ja) * 1996-10-28 2001-03-13 ディパートメント オブ ジ アーミー，ユー．エス．ガバメント 抗生物質耐性感染症の処置のための化合物、組成物および方法
JP4120713B2 (ja) * 1997-09-04 2008-07-16 大塚製薬株式会社 多発性硬化症治療剤
US6077851A (en) * 1998-04-27 2000-06-20 Active Biotech Ab Quinoline derivatives
SE9802549D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
SE9802550D0 (sv) * 1998-07-15 1998-07-15 Active Biotech Ab Quinoline derivatives
US6133285A (en) * 1998-07-15 2000-10-17 Active Biotech Ab Quinoline derivatives
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
AU2011314411B2 (en) * 2010-10-14 2014-06-12 Immunahr Ab 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as AhR activators.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE52670B1 (en) 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
US5310913A (en) * 1989-06-09 1994-05-10 Kabi Pharmacia Aktiebolag Derivatives of quinoline-3-carboxanilide

Also Published As

Publication number Publication date
KR940702726A (ko) 1994-09-17
US5580882A (en) 1996-12-03
NO941273L (no) 1994-06-08
EP0607282A1 (en) 1994-07-27
WO1993006829A1 (en) 1993-04-15
SE9102909D0 (sv) 1991-10-09
NO941273D0 (no) 1994-04-08
SE469368B (sv) 1993-06-28
JPH06511488A (ja) 1994-12-22
SE9102909L (sv) 1993-04-10
AU653647B2 (en) 1994-10-06
PT100937A (pt) 1994-01-31
AU2770892A (en) 1993-05-03
CA2120712A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
DK0515312T3 (da) Farmaceutisk præparat
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
FI934914A (fi) Farmaceutiska formuleringar
NO179941C (no) Farmasöytisk forbindelse
NO923127L (no) Farmasoeytisk kombinasjonsformulering
BR9200058A (pt) Composto e composicao farmaceutica
EE9400257A (et) Kinoliin-3-karboksamiidi ühendi kasutamine ravimkompositsiooni valmistamiseks
MX9200622A (es) Composicion farmaceutica
NO924885D0 (no) Fremgangsmaate for fremstilling av syntesegass
DK645788D0 (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO934145L (no) Farmasöytiske forbindelser
MX9200146A (es) Composiciones farmaceuticas deglutibles
IT1290797B1 (it) Composizioni farmaceutiche stabilizzate
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
DK49791D0 (da) Nasalt pulverpraeparat
FI97951B (fi) Menetelmä kiinteiden oraalisesti käytettävien ifosfamidivalmisteiden valmistamiseksi
EE03090B1 (et) Kinoliin-3-karboksamiidühendite kasutamine kompositsiooni valmistamiseks I tüüpi suhkurtõve raviks
DK196591D0 (da) Anvendelse af en kendt kemisk forbindelse til fremstilling af et farmaceutisk paraeparat til topisk applikation
FI921786A (fi) Farmaceutisk foerening
FI921785A (fi) Farmaceutisk foerening
NO922709D0 (no) Fremgangsmaate for fremstilling av vanadium-bis-arener
NO921538D0 (no) Fremgangsmaate for fremstilling av et glycidylazid-polymerazid
ITMI942130A0 (it) Procedimento di preparazione di composizioni orali contenenti chinoloni
BR9206845A (pt) Composto famacêutico